Neuphoria therapeutics inc.NEUP.US Overview

US StockHealthcare

(No presentation for NEUP)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

NEUP Overall Performance

NEUP AI Analysis & Strategy

NEUP Recent Performance

-1.80%

Neuphoria therapeutics inc.

0.81%

Avg of Sector

-1.14%

S&P500

NEUP PowerScanner

NEUP Key Information

NEUP Valuation Metrics

NEUP Earnings Table

NEUP Profile

Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.